Marimed (MRMD) Payables (2011 - 2026)

Marimed (MRMD) has 16 years of Payables data on file, last reported at $18.4 million in Q1 2026.

• Payables for Q1 2026 came in at $18.4 million, down 1.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $18.4 million (down 1.87% YoY), and the FY2025 annual result was $17.1 million, down 6.42% from the prior year.
• Payables grew to $18.4 million in Q1 2026 per MRMD's latest filing, from $17.1 million in the prior quarter.
• Over five years, Payables peaked at $18.8 million in Q1 2025 and troughed at $4.8 million in Q1 2023.
• A 5-year average of $12.2 million and a median of $11.3 million in 2024 frame the typical range for Payables.
• The sharpest annual moves came in 2023 and 2024: Payables sank 42.8% in 2023, then soared 137.67% in 2024.
• A 5-year view of Payables shows it stood at $10.4 million in 2022, then dropped by 6.5% to $9.7 million in 2023, then jumped by 88.35% to $18.3 million in 2024, then declined by 6.42% to $17.1 million in 2025, then grew by 7.38% to $18.4 million in 2026.
• Business Quant data shows MRMD's Payables at $18.4 million in Q1 2026, $17.1 million in Q4 2025, and $13.6 million in Q3 2025.